Evidence map›Paper›PMID 36134186›Full record

ReviewNanoscale advances2021

Nanomaterial-based encapsulation for controlled gastrointestinal delivery of viable probiotic bacteria.

Seyedehhamideh Razavi, Sajjad Janfaza, Nishat Tasnim, Deanna L Gibson, Mina Hoorfar

Abstract readReview
In one paragraph

Review in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Smart CaCOScientific reports · 2026
    Article
  6. Probiotic-Based Materials as Living Therapeutics.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seyedehhamideh RazaviSchool of Engineering, University of British Columbia Kelowna BC Canada mina.hoorfar@ubc.ca.
Sajjad JanfazaSchool of Engineering, University of British Columbia Kelowna BC Canada mina.hoorfar@ubc.ca.
Nishat TasnimSchool of Engineering, University of British Columbia Kelowna BC Canada mina.hoorfar@ubc.ca.ORCID https://orcid.org/0000-0002-9899-2014
Deanna L GibsonDepartment of Biology, Faculty of Science, University of British Columbia Kelowna Canada.
Mina HoorfarSchool of Engineering, University of British Columbia Kelowna BC Canada mina.hoorfar@ubc.ca.ORCID https://orcid.org/0000-0002-2665-7532

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are microorganisms that have beneficial health effects when administered in adequate dosages. The oral administration of probiotic bacteria is widely considered beneficial for both intestinal as well as systemic health but its clinical efficacy is conflicted in the literature. This may at least in part be due to the loss of viability during gastrointestinal passage resulting in poor intestinal delivery. Microencapsulation technology has been proposed as a successful strategy to address this problem by maintaining the viability of probiotics, thereby improving their efficacy following oral administration. More recently, nanomaterials have demonstrated significant promise as encapsulation materials to improve probiotic encapsulation. The integration of nanotechnology with microencapsulation techniques can improve the controlled delivery of viable probiotic bacteria to the gut. The current review aims at summarizing the types of nanomaterials used for the microencapsulation of probiotics and showing how they can achieve the delivery and controlled release of probiotics at the site of action.

Identifiers

PMID36134186
PMCPMC9419840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.